Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Apr;15(4):5781-5786.
doi: 10.3892/ol.2018.8013. Epub 2018 Feb 9.

Rapamycin promotes the anticancer action of dihydroartemisinin in breast cancer MDA-MB-231 cells by regulating expression of Atg7 and DAPK

Qiujun Liu  1   2 , Xianyao Zhou  2 , Chuan Li  2 , Xuemei Zhang  2 , Chang Long Li  2
Affiliations

Rapamycin promotes the anticancer action of dihydroartemisinin in breast cancer MDA-MB-231 cells by regulating expression of Atg7 and DAPK

Qiujun Liu et al. Oncol Lett. 2018 Apr.

Abstract

There is limited knowledge regarding the influence of autophagy on the anticancer effect of dihydroartemisinin (DHA). The present study aimed to investigate this influence within human breast cancer cells. Changes in cell viability, cell cycle distribution, apoptosis and associated genes were analyzed in MDA-MB-231 cells subjected to DHA following alteration in autophagy levels; the autophagy level was decreased following autophagy-related 7 (Atg7) knockdown or increased using rapamycin. The data indicated that rapamycin had the ability to notably enhance the anticancer effect of DHA on MDA-MB-231 cells. Autophagy induction may be key in mediating the anticancer effects of DHA, and rapamycin may regulate the death-associated protein kinase via the alteration of Atg7 expression, which would influence cell apoptosis. The present study presented a novel insight into enhancing the effectiveness of future treatment regimens for breast cancer using DHA.

Keywords: MDA-MB-231; autophagy; autophagy-related 7 small interfering RNA; breast cancer; dihydroartemisinin; rapamycin.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Autophagy induction promoted the death of DHA-treated MDA-MB-231 breast cancer cells. Rapamycin inhibited proliferation and Atg7 deficiency promoted survival in DHA-treated MDA-MB-231 breast cancer cells. MDA-MB-231 cells were examined an MTT assay (6, 12, 24, 48 and 72 h), normalized to the cell viability of control-MDA-MB-231 cells. This figure indicated that Atg7 knockdown increased the viability of MDA-MB-231 breast cancer cells and rapamycin decreased the viability. This graph indicates that Atg7 may function as a promoter of the anticancer effect of DHA. These data indicated that Atg7 knockdown facilitated the survival of MDA-MB-231 breast cancer cells, whereas rapamycin treatment enhanced the DHA action on this breast cancer cell line. DHA, dihydroartemisinin; Atg7, autophagy-related 7. *P<0.05.
Figure 2.
Figure 2.
Atg7 may regulate DAPK to inhibit proliferation of the MDA-MB-231 cells. The mRNA levels of Atg7 increased, and DAPK changed accordingly. Atg7 and DAPK gene expressions in the DHA-treated MDA-MB-231 cells at 24 h were determined by reverse transcription-quantitative polymerase chain reaction (β-actin was used as a reference). The expression levels of Atg7 and DAPK increased in the rapamycin group, and decreased in the Atg7-knockdown group. DHA, dihydroartemisinin; Atg7, autophagy-related 7; DAPK, death-associated protein kinase. *P<0.05.
Figure 3.
Figure 3.
Rapamycin enhanced the pro-apoptotic effect of DHA in MDA-MB-231 cells. Cell cycle distribution and the proportion of apoptotic cells were detected using a flow cytometer at 24 and 48 h. (A) Cell numbers during the apoptotic phase (SubG1) of the MDA-MB-231 cells at 24 h. (B) Cell numbers during the apoptotic phase (SubG1) in the MDA-MB-231 cells at 48 h. Treatment with rapamycin notably promoted the effect of DHA on apoptosis at 24 and 48 h, compared with the Atg7 deficient group. (C) Cell cycle distribution and apoptosis graphs from flow cytometry. DHA, dihydroartemisinin; Atg7, autophagy-related 7; PI, propidium iodide. *P<0.05.
See this image and copyright information in PMC

References

    1. Plucinski MM, Dimbu PR, Macaia AP, Ferreira CM, Samutondo C, Quivinja J, Afonso M, Kiniffo R, Mbounga E, Kelley JS, et al. Efficacy of artemether-lumefantrine, artesunate-amodiaquine, and dihydroartemisinin-piperaquine for treatment of uncomplicated Plasmodium falciparum malaria in Angola, 2015. Malar J. 2017;16:62. doi: 10.1186/s12936-017-1712-4. - DOI - PMC - PubMed
    1. Thanh NV, Thuy-Nhien N, Tuyen NT, Tong NT, Nha-Ca NT, Dong LT, Quang HH, Farrar J, Thwaites G, White NJ, et al. Rapid decline in the susceptibility of Plasmodium falciparum to dihydroartemisinin-piperaquine in the south of Vietnam. Malar J. 2017;16:27. doi: 10.1186/s12936-017-1680-8. - DOI - PMC - PubMed
    1. Mao H, Gu H, Qu X, Sun J, Song B, Gao W, Liu J, Shao Q. Involvement of the mitochondrial pathway and Bim/Bcl-2 balance in dihydroartemisinin-induced apoptosis in human breast cancer in vitro. Int J Mol Med. 2013;31:213–218. doi: 10.3892/ijmm.2012.1176. - DOI - PubMed
    1. Singh NP, Lai HC, Park JS, Gerhardt TE, Kim BJ, Wang S, Sasaki T. Effects of artemisinin dimers on rat breast cancer cells in vitro and in vivo. Anticancer Res. 2011;31:4111–4114. - PubMed
    1. Lai H, Nakase I, Lacoste E, Singh NP, Sasaki T. Artemisinin-transferrin conjugate retards growth of breast tumors in the rat. Anticancer Res. 2009;29:3807–3810. - PubMed